| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1019152547 |
| P356 | DOI | 10.1038/SJ.ONC.1209791 |
| P698 | PubMed publication ID | 16832347 |
| P5875 | ResearchGate publication ID | 6953978 |
| P2093 | author name string | Martin PM | |
| Sturgill TW | |||
| Hussaini IM | |||
| Chrestensen CA | |||
| Aeder SE | |||
| P2860 | cites work | Phorbol 12-myristate 13-acetate induces protein kinase ceta-specific proliferative response in astrocytic tumor cells | Q22254077 |
| Protein kinase C-eta regulates resistance to UV- and gamma-irradiation-induced apoptosis in glioblastoma cells by preventing caspase-9 activation | Q24292077 | ||
| Rictor, a novel binding partner of mTOR, defines a rapamycin-insensitive and raptor-independent pathway that regulates the cytoskeleton | Q24299873 | ||
| Insulin-dependent stimulation of protein synthesis by phosphorylation of a regulator of 5'-cap function | Q24324452 | ||
| RAFT1 phosphorylation of the translational regulators p70 S6 kinase and 4E-BP1 | Q24682697 | ||
| Enhanced sensitivity of PTEN-deficient tumors to inhibition of FRAP/mTOR. | Q27824772 | ||
| TOR, a central controller of cell growth | Q27933354 | ||
| Rapamycin-FKBP specifically blocks growth-dependent activation of and signaling by the 70 kd S6 protein kinases | Q28187456 | ||
| Mechanisms of resistance to rapamycins | Q28198092 | ||
| Phosphatidic acid-mediated mitogenic activation of mTOR signaling | Q28208274 | ||
| The role of protein kinase C in cell surface signal transduction and tumour promotion | Q29618532 | ||
| The molecular heterogeneity of protein kinase C and its implications for cellular regulation | Q29619947 | ||
| Regulation of translation initiation by FRAP/mTOR | Q29620398 | ||
| PKC-eta mediates glioblastoma cell proliferation through the Akt and mTOR signaling pathways | Q30434836 | ||
| Requirements for therapeutic drug monitoring of sirolimus, an immunosuppressive agent used in renal transplantation | Q33925685 | ||
| 4E-binding proteins, the suppressors of eukaryotic initiation factor 4E, are down-regulated in cells with acquired or intrinsic resistance to rapamycin | Q34114303 | ||
| Malignant glioma: genetics and biology of a grave matter. | Q34272357 | ||
| Transduction of growth or mitogenic signals into translational activation of TOP mRNAs is fully reliant on the phosphatidylinositol 3-kinase-mediated pathway but requires neither S6K1 nor rpS6 phosphorylation | Q34286691 | ||
| Efficient gene transfer into the human natural killer cell line, NKL, using the Amaxa nucleofection system | Q34291484 | ||
| Tor signalling in bugs, brain and brawn | Q35058522 | ||
| Targeted molecular therapy of GBM. | Q35064179 | ||
| Molecular analysis of glioblastoma: pathway profiling and its implications for patient therapy | Q35184074 | ||
| PKC at a glance. | Q35607952 | ||
| Mammalian target of rapamycin (mTOR) Inhibitors | Q35642619 | ||
| The principal rapamycin-sensitive p70(s6k) phosphorylation sites, T-229 and T-389, are differentially regulated by rapamycin-insensitive kinase kinases | Q40020238 | ||
| Determinants of rapamycin sensitivity in breast cancer cells | Q40590648 | ||
| AKT activity determines sensitivity to mammalian target of rapamycin (mTOR) inhibitors by regulating cyclin D1 and c-myc expression | Q40623520 | ||
| Spontaneous activation and signaling by overexpressed epidermal growth factor receptors in glioblastoma cells | Q40676718 | ||
| The principal target of rapamycin-induced p70s6k inactivation is a novel phosphorylation site within a conserved hydrophobic domain. | Q40789796 | ||
| Signal transduction pathways and their relevance in human astrocytomas | Q40872114 | ||
| Regulation of eIF-4E BP1 phosphorylation by mTOR. | Q41087062 | ||
| Rapamycin suppresses 5'TOP mRNA translation through inhibition of p70s6k. | Q41106936 | ||
| Rapamycin, wortmannin, and the methylxanthine SQ20006 inactivate p70s6k by inducing dephosphorylation of the same subset of sites | Q41666761 | ||
| mTOR, a novel target in breast cancer: the effect of CCI-779, an mTOR inhibitor, in preclinical models of breast cancer | Q42660087 | ||
| Phospholipase D confers rapamycin resistance in human breast cancer cells | Q44482361 | ||
| PKC alpha mediates chemoresistance in acute lymphoblastic leukemia through effects on Bcl2 phosphorylation | Q44737480 | ||
| Dysregulation of protein kinase C activity in chemoresistant metastatic breast cancer cells | Q44795619 | ||
| Sirolimus-eluting stents in the canine cerebral vasculature: a prospective, randomized, blinded assessment of safety and vessel response | Q44834396 | ||
| Phase II trial of temsirolimus (CCI-779) in recurrent glioblastoma multiforme: a North Central Cancer Treatment Group Study | Q46585156 | ||
| Oncogenic Ras and Akt Signaling Contribute to Glioblastoma Formation by Differential Recruitment of Existing mRNAs to Polysomes | Q47421825 | ||
| Functional and molecular analyses of 10q deletions in human gliomas | Q48306512 | ||
| Activation of the phosphatidylinositol-3'-kinase/protein kinase B-dependent antiapoptotic pathway plays an important role in the development of radioresistance of human glioma cells | Q48424881 | ||
| Phosphatidic acid activation of protein kinase C in LA-N-1 neuroblastoma cells | Q71485279 | ||
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 407-414 | |
| P577 | publication date | 2006-07-10 | |
| P1433 | published in | Oncogene | Q1568657 |
| P1476 | title | Phorbol 12-myristate 13-acetate and serum synergize to promote rapamycin-insensitive cell proliferation via protein kinase C-eta | |
| P478 | volume | 26 |
| Q42470449 | A Role for the Cavin-3/Matrix Metalloproteinase-9 Signaling Axis in the Regulation of PMA-Activated Human HT1080 Fibrosarcoma Cell Neoplastic Phenotype |
| Q92276992 | Inhibition of protein kinase C activity inhibits osteosarcoma metastasis |
| Q33389634 | Multivariate gene expression analysis reveals functional connectivity changes between normal/tumoral prostates |
| Q90285576 | PBX3/MEK/ERK1/2/LIN28/let-7b positive feedback loop enhances mesenchymal phenotype to promote glioblastoma migration and invasion |
| Q59072618 | Protein Kinase C (PKC) Isozymes and Cancer |
| Q35149607 | Tumor promoter-induced cellular senescence: cell cycle arrest followed by geroconversion |
Search more.